PuSH - Publication Server of Helmholtz Zentrum München

141 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
121.
Kanoni, S.* et al.: Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: A 14-cohort meta-analysis. Diabetes 60, 2407-2416 (2011)
122.
Pflueger, M. et al.: Age- and islet autoimmunity-associated differences in amino acid and lipid metabolites in children at risk for type 1 diabetes. Diabetes 60, 2740-2747 (2011)
123.
Renström, F.* et al.: Genetic predisposition to long-term nondiabetic deteriorations in glucose homeostasis: Ten-year follow-up of the GLACIER study. Diabetes 60, 345-354 (2011)
124.
Strawbridge, R.J.* et al.: Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes. Diabetes 60, 2624-2634 (2011)
125.
Winkler, C. et al.: An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes 60, 685-690 (2011)
126.
Soranzo, N.* et al.: Common variants at 10 genomic loci influence hemoglobin A₁C levels via glycemic and nonglycemic pathways. Diabetes 59, 3229-3239 (2010)
127.
Winkler, C. et al.: BMI at age 8 years is influenced by the type 2 diabetes susceptibility genes HHEX-IDE and CDKAL1. Diabetes 59, 2063-2067 (2010)
128.
Laumen, H.* et al.: Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 58, 984-991 (2009)
129.
Wiedmann, S.* et al.: Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57, 209-217 (2008)
130.
Herbach, N.* et al.: Dominant-Negative Effects of a Novel Mutated Ins2 Allele Causes Early-Onset Diabetes and Severe ß-Cell Loss in Munich Ins2C95S Mutant Mice. Diabetes 56, 1268-1276 (2007)
131.
Endl, J.* et al.: Co-expression of CD25 and Ox40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes. Diabetes 55, 50-60 (2006)
132.
Gray, S.L.* et al.: Leptin deficiency unmasks the deleterious effects of impaired peroxisome proliferator-activated receptor gamma function (P465L PPARgamma) in mice. Diabetes 55, 2669-2677 (2006)
133.
Heid, I.M. et al.: Genetic architecture of the APM1 gene and its influence on adiponectin plasma levels anmd parameters of the metabolic syndrome in 1,727 healthy Caucasians. Diabetes 55, 375-384 (2006)
134.
Huth, C. et al.: IL6 gene promoter polymorphisms and type 2 diabetes: Joint analysis of individual participants' data from 21 studies. Diabetes 55, 2915-2921 (2006)
135.
Schoenborn, V.* et al.: The ATGL gene is associated with free fatty acids, triglycerides and type 2 diabetes. Diabetes 55, 1270-1275 (2006)
136.
Baessler, A.* & Döring, A.: Genetic linkage and association of the growth hormone secretagogue receptor (Ghrelin receptor) gene in human obesity. Diabetes 54, 259-267 (2005)
137.
Herder, Ch.* et al.: Association of Systemic Chemokine Concentrations with Impaired Glucose Tolerance and Type 2 Diabetes: Results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4). Diabetes 54, 2, 11-17 (2005)
138.
Thorand, B. et al.: Elevated levels of interleukin-18 predict the development of type 2 diabetes: Results from the MONICA/KORA Augsburg Study, 1984-2002. Diabetes 54, 2932-2938 (2005)
139.
Cabeza, N.* et al.: Surface expression of collagen receptor Fc receptor-gamma/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells. Diabetes 53, 2117-2121 (2004)
140.
Illig, T. et al.: The endotoxin receptor TLR4 polymorphism is not associated with diabetes or components of the metabolic syndrome. Diabetes 52, 2861-2864 (2003)